Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.

@article{Hannan2008DrugelutingSV,
  title={Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.},
  author={E. Hannan and C. Wu and G. Walford and A. Culliford and J. Gold and C. Smith and R. Higgins and Russell E Carlson and R. Jones},
  journal={The New England journal of medicine},
  year={2008},
  volume={358 4},
  pages={
          331-41
        }
}
  • E. Hannan, C. Wu, +6 authors R. Jones
  • Published 2008
  • Medicine
  • The New England journal of medicine
  • BACKGROUND Numerous studies have compared the outcomes of two competing interventions for multivessel coronary artery disease: coronary-artery bypass grafting (CABG) and coronary stenting. However, little information has become available since the introduction of drug-eluting stents. METHODS We identified patients with multivessel disease who received drug-eluting stents or underwent CABG in New York State between October 1, 2003, and December 31, 2004, and we compared adverse outcomes (death… CONTINUE READING

    Paper Mentions

    OBSERVATIONAL CLINICAL TRIAL
    Title Prospective, single-arm, multi-centre, observational registry to further validate safety and efficacy of the Nobori® DES in real-world patients. Objective Primary objective… Expand
    ConditionsCoronary Artery Disease

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 39 REFERENCES